Alberto Broniscer, M.D.

  • Director, Pediatric Neuro-Oncology Program, UPMC Children's Hospital of Pittsburgh
  • Visiting Professor of Pediatrics, University of Pittsburgh School of Medicine

Dr. Broniscer joined the faculty as the Director of the Pediatric Neuro Oncology Program at UPMC Children’s Hospital of Pittsburgh in August 2017. His clinical expertise is the treatment of infants, children, adolescents, and young adults with brain and spinal cord cancers.

Once Dr. Broniscer completed his graduate and post-graduate training, he joined the faculty at St. Jude Children’s Research Hospital in July 2002. Dr. Broniscer worked at St. Jude as a full-time pediatric neuro-oncologist until July 2017.

Education & Training

  • MD-São Paulo University Medical School, São Paulo, Brazil
  • Pediatric Residency-São Paulo University Medical School, São Paulo, Brazil
  • Pediatric Hematology-Oncology Fellowship-São Paulo University Medical School, São Paulo, Brazil
  • Pediatric Hematology-Oncology Fellowship-St. Jude Children’s Research Hospital, Memphis, TN
  • Pediatric Neuro-Oncology Fellowship-St. Jude Children’s Research Hospital, Memphis, TN
  • Pediatric Residency-The Federal University of São Paulo, São Paulo, Brazil
  • Pediatric Residency-North Shore University Hospital, Manhasset, NY
  • Neuro-Oncology Fellowship-New York University, New York, NY
  • Neuro-Oncology Fellowship-Johns Hopkins Hospital, Baltimore, MD
  • Masters of Sciences-São Paulo University Medical School, São Paulo, Brazil

Representative Publications

Research Interests

Dr. Broniscer has a great interest in conducting research in different areas associated with brain and spinal cord cancers in children. He has conducted several single and multi-institutional Phase 1 and 2 clinical trials in the treatment of children with brain and spinal cord tumors & is particularly interested in developing new treatments based on biological characteristics of these tumors.

Although Dr. Broniscer was focused in the development of innovative clinical trials for children with high-grade gliomas, diffuse intrinsic pontine gliomas, and atypical teratoid rhabdoid tumors at St. Jude, he plans to continue these efforts for a broader range of brain and spinal cord tumors at the UPMC Children's Hospital of Pittsburgh.

Dr. Broniscer has great interest in conducting clinical and molecular studies to increase the understanding about rare and aggressive types of pediatric brain cancers. He has conducted multiple such studies in the past in collaboration with pathologists and translational scientists. Dr. Broniscer has also conducted one of the first prospective biologic studies in the US based on tumor tissue collected at autopsy.

Dr. Broniscer has a particular interest in cancer predisposition conditions and genetic/inherited aspects of brain and spinal cord cancers in children.

Dr. Broniscer has published approximately 100 original manuscripts and 7 reviews/book chapters published.

Division